Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:cyclosporin A
go back to main search page
Accession:CHEBI:4031 term browser browse the term
Definition:A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle.
Synonyms:exact_synonym: 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
 related_synonym: (R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl);   1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine];   30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;   Antibiotic S 7481F1;   Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl);   Cyclosporine;   Formula=C62H111N11O12;   Gengraf;   InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42+,43-,44+,45-,46+,47+,49+,50-,51+,52-/m1/s1;   InChIKey=PMATZTZNYRCHOR-CGLBZJNRSA-N;   Neoral;   SMILES=CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\\C=C\\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C;   Sandimmune;   ciclosporin;   ciclosporina;   ciclosporine;   ciclosporinum
 alt_id: CHEBI:63586;   CHEBI:91802
 xref: Beilstein:3647785 "Beilstein";   CAS:59865-13-3 "ChemIDplus";   CAS:59865-13-3 "KEGG COMPOUND";   DrugBank:DB00091;   Drug_Central:760 "DrugCentral";   KEGG:C05086;   KEGG:D00184;   KNApSAcK:C00001517;   LINCS:LSM-1703
 xref_mesh: MESH:D016572
 xref: PMID:11058832 "Europe PMC";   PMID:11069928 "Europe PMC";   PMID:11079273 "Europe PMC";   PMID:11080188 "Europe PMC";   PMID:11238591 "Europe PMC";   PMID:11256490 "Europe PMC";   PMID:11278005 "Europe PMC";   PMID:11315347 "Europe PMC";   PMID:11370709 "Europe PMC";   PMID:11406057 "Europe PMC";   PMID:11426833 "Europe PMC";   PMID:11442023 "Europe PMC";   PMID:11481617 "Europe PMC";   PMID:11493684 "Europe PMC";   PMID:11529914 "Europe PMC";   PMID:11557554 "Europe PMC";   PMID:11564166 "Europe PMC";   PMID:11676831 "Europe PMC";   PMID:11870366 "Europe PMC";   PMID:12021257 "Europe PMC";   PMID:12050171 "Europe PMC";   PMID:12603598 "Europe PMC";   PMID:12761440 "Europe PMC";   PMID:12929192 "Europe PMC";   PMID:12950728 "Europe PMC";   PMID:14521916 "Europe PMC";   PMID:14621732 "Europe PMC";   PMID:14638917 "Europe PMC";   PMID:14672695 "Europe PMC";   PMID:14682659 "Europe PMC";   PMID:14743390 "Europe PMC";   PMID:15030555 "Europe PMC";   PMID:15175101 "Europe PMC";   PMID:15210365 "Europe PMC";   PMID:15306697 "Europe PMC";   PMID:15383526 "Europe PMC";   PMID:15541012 "Europe PMC";   PMID:15613074 "Europe PMC";   PMID:15626898 "Europe PMC";   PMID:15657176 "Europe PMC";   PMID:1566062 "Europe PMC";   PMID:15711594 "Europe PMC";   PMID:15811524 "Europe PMC";   PMID:15962181 "Europe PMC";   PMID:16372476 "Europe PMC";   PMID:16404634 "Europe PMC";   PMID:16724420 "Europe PMC";   PMID:16801218 "Europe PMC";   PMID:16898534 "Europe PMC";   PMID:17032751 "Europe PMC";   PMID:17083576 "Europe PMC";   PMID:17117422 "Europe PMC";   PMID:17192032 "Europe PMC";   PMID:17220244 "Europe PMC";   PMID:17229932 "Europe PMC";   PMID:17265451 "Europe PMC";   PMID:17446460 "Europe PMC";   PMID:17603747 "Europe PMC";   PMID:18076075 "Europe PMC";   PMID:18171316 "Europe PMC";   PMID:18191430 "Europe PMC";   PMID:18217899 "Europe PMC";   PMID:18259730 "Europe PMC";   PMID:18299432 "Europe PMC";   PMID:18359899 "Europe PMC";   PMID:18583716 "Europe PMC";   PMID:18597363 "Europe PMC";   PMID:18790203 "Europe PMC";   PMID:18818682 "Europe PMC";   PMID:18931077 "Europe PMC";   PMID:18975184 "Europe PMC";   PMID:19282398 "Europe PMC";   PMID:19589783 "Europe PMC";   Patent:US4117118;   Reaxys:3647785 "Reaxys";   VSDB:1765;   Wikipedia:Ciclosporin


show annotations for term's descendants       view all columns           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 20971
    role 20952
      biological role 20950
        biochemical role 19959
          metabolite 19886
            cyclosporin A 8376
              cyclosporin A derivative + 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 20971
    subatomic particle 20965
      composite particle 20965
        hadron 20965
          baryon 20965
            nucleon 20965
              atomic nucleus 20965
                atom 20965
                  main group element atom 20803
                    p-block element atom 20803
                      carbon group element atom 20543
                        carbon atom 20519
                          organic molecular entity 20519
                            organic group 19168
                              organic divalent group 19158
                                organodiyl group 19158
                                  carbonyl group 19130
                                    carbonyl compound 19130
                                      carboxylic acid 18806
                                        carboacyl group 17435
                                          univalent carboacyl group 17435
                                            carbamoyl group 17133
                                              carboxamide 17133
                                                peptide 9414
                                                  cyclic peptide 8835
                                                    homodetic cyclic peptide 8405
                                                      cyclosporin A 8376
                                                        cyclosporin A derivative + 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.